Involvement of the monoamine system in antidepressant-like properties of 4-(1-phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester

详细信息    查看全文

• 作者：Pablinny Moreira Galdino^a ; ^f ; Danillo Ramos de Oliveira^a ; Iziara Ferreira Florentino^a ; James Oluwagbamigbe Fajemiroye^a ; Marize Campos Valadares^b ; Soraia Santana de Moura^b ; Fá ; bio Fagundes da Rocha^c ; Thereza Christina Monteiro de Lima^d ; Elson Alves Costa^a ; ^{xico@ufg.br" class="auth_mail" title="E-mail the corresponding author} ; Ricardo Menegatti^e
• 关键词：Antidepressant-like effect ; BDNF ; MAO activity ; AMPT ; PCPA
• 刊名：Life Sciences
• 出版年：2015
• 出版时间：15 December 2015
• 年：2015
• 卷：143
• 期：Complete
• 页码：187-193
• 全文大小：572 K

文摘

Piperazinic derivatives have therapeutic potential by acting as analgesic, antidepressant-like, anticonvulsant and antipsychotic in preclinical studies. In order to develop new drugs to treat mental disorders, we designed and synthesized the 4-(1-phenyl-1H-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester (PPMP), a new piperazine derivative with putative activities on central nervous system that seems to involve serotonergic system.

Materials and methods

In order to investigate the antidepressant-like activity of PPMP, mice were treated acutely and tested in the forced swimming test (FST) and tail suspension test. Pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., 4 days), and the non-selective blocker of catecholamine synthesis α-methyl para-tyrosine (AMPT, 100 mg/kg, i.p.) were used to assay the involvement of serotonergic and catecholaminergic systems. “Ex vivo” monoamine oxidase (MAO) enzymatic assay and quantification of hippocampal level of brain derived neurotrophic factor (BDNF) were carried out.

Key findings

PPMP reduced the immobility time in both tests. PCPA or AMPT (100 mg/kg, i.p.) pretreatment blocked the effects of PPMP, thereby suggesting the involvement of serotonergic and catecholaminergic systems in the antidepressant-like effect of PPMP. PPMP did not inhibit the activity of MAO. Moreover, after 14 days of treatment, PPMP 15 mg/kg/day induced antidepressant-like effect and increased hippocampal level of BDNF. None of the treatments in this study altered the locomotor activity in the open field test.

Significance

In conclusion, PPMP demonstrates antidepressant-like effect that involve both serotonergic and catecholaminergic systems without inhibition of MAO activity. PPMP administration increased the hippocampal levels of BDNF.